This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.62% per year. These returns cover a period from January 1, 1988 through June 2, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
earnings-outlook: Archive
Home BancShares (HOMB) Meets Q2 Earnings Estimates
by Zacks Equity Research
Home BancShares (HOMB) delivered earnings and revenue surprises of 0.00% and +3.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
HOMBPositive Net Change TCBXPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Synovus Financial (SNV) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Synovus (SNV) delivered earnings and revenue surprises of +18.40% and +1.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SNVPositive Net Change CUBIPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
First Industrial Realty Trust (FR) Surpasses Q2 FFO and Revenue Estimates
by Zacks Equity Research
First Industrial Realty Trust (FR) delivered FFO and revenue surprises of +5.56% and +2.40%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
FRPositive Net Change DRHNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
South Plains Financial (SPFI) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
South Plains Financial (SPFI) delivered earnings and revenue surprises of +11.69% and +5.74%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
SPFIPositive Net Change CHMGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Monarch Casino (MCRI) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Monarch Casino (MCRI) delivered earnings and revenue surprises of +18.03% and +5.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
MCRIPositive Net Change LNWPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Rexford Industrial (REXR) Q2 FFO and Revenues Top Estimates
by Zacks Equity Research
Rexford Industrial (REXR) delivered FFO and revenue surprises of +1.72% and +1.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
REXRPositive Net Change KRCNegative Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
AAR (AIR) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
AAR (AIR) delivered earnings and revenue surprises of +16.00% and +9.19%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?
AIRPositive Net Change DRSPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Kinder Morgan (KMI) Meets Q2 Earnings Estimates
by Zacks Equity Research
Kinder Morgan (KMI) delivered earnings and revenue surprises of 0.00% and +4.11%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
KMINegative Net Change WMBPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JNJPositive Net Change LLYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Johnson & Johnson (JNJ) Surpasses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Johnson & Johnson (JNJ) delivered earnings and revenue surprises of +4.14% and +4.13%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
JNJPositive Net Change LLYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
What Makes Safran (SAFRY) a New Strong Buy Stock
by Zacks Equity Research
Safran (SAFRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
SAFRYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
East West Bancorp (EWBC) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
East West Bancorp (EWBC) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
EWBCPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Taysha Gene Therapies (TSHA) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Taysha Gene Therapies (TSHA) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
TSHAPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Yara International ASA (YARIY) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Yara International ASA (YARIY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
YARIYPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Akebia Therapeutics (AKBA) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Akebia Therapeutics (AKBA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
AKBAPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Regions Financial (RF) Rating Upgrade to Buy
by Zacks Equity Research
Regions Financial (RF) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
RFPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Kiora Pharmaceuticals (KPRX) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Kiora Pharmaceuticals (KPRX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
KPRXPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Corteva, Inc. (CTVA) Upgraded to Strong Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Corteva, Inc. (CTVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
CTVAPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Boyd (BYD) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Boyd (BYD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BYDPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
All You Need to Know About Immunovant (IMVT) Rating Upgrade to Buy
by Zacks Equity Research
Immunovant (IMVT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
IMVTPositive Net Change
earnings-estimates earnings-estimates-revisions earnings-outlook rating-upgrade stock-price-movement zacks-consensus-estimate zacks-rank
Plumas Bancorp (PLBC) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Plumas Bancorp (PLBC) delivered earnings and revenue surprises of -12.50% and -1.94%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PLBCNegative Net Change FSBWPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Progressive (PGR) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Progressive (PGR) delivered earnings and revenue surprises of +10.16% and +0.51%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PGRPositive Net Change HIGPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Community Trust Bancorp (CTBI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Community Trust Bancorp (CTBI) delivered earnings and revenue surprises of +8.66% and +3.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
CTBIPositive Net Change RNSTPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
Prologis (PLD) Tops Q2 FFO and Revenue Estimates
by Zacks Equity Research
Prologis (PLD) delivered FFO and revenue surprises of +3.55% and +1.35%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
PLDPositive Net Change GTYPositive Net Change
earnings earnings-estimates earnings-outlook earnings-surprise industry-outlook zacks-consensus-estimate zacks-rank
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
PAASNegative Net Change ATINegative Net Change
earnings-esp earnings-expectations earnings-outlook